Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
SCTV01C + SCTV01E
- Development stage
- Unknown
- Lead developer
- Sinocelltech
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
SCTV01C and SCTV01E are recombinant protein-based COVID-19 vaccines developed by Sinocelltech. SCTV01C is a bivalent vaccine containing spike protein ectodomain (S-ECD) antigens from the SARS-CoV-2 Alpha and Beta variants. SCTV01E is a tetravalent vaccine containing recombinant S trimer protein antigens from four variants: Alpha (B.1.1.7), Beta (B.1.351), Delta (B.1.617.2), and Omicron (BA.1). Both vaccines are formulated with an oil-in-water emulsion adjuvant and are intended for use as booster doses to induce broad neutralizing antibody responses. SCTV01C received Emergency Use Authorization (EUA) in China in December 2022, followed by SCTV01E in March 2023.
- Other names
- SCTV01CSCTV-01CSCTV 01CSCTV01ESCTV-01ESCTV 01E
02
Targets
SARS-CoV-2 spike
Beyond the preview
Go deeper on SCTV01C + SCTV01E.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SCTV01C + SCTV01E.